---
layout: post
title: "【图解年报】华大基因：2021年归母净利润下降30.1%，降幅超营收"
date: 2022-04-22 19:29:33 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p>华大基因于2022年4月23日披露年报，公司2021年实现营业总收入67.7亿，同比下降19.4%；实现归母净利润14.6亿，同比下降30.1%；每股收益为3.56元。</p><img id="image7" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2CA3965BA3ED9B08EE266257B34A631FE_w800h400.jpg" alt=""><p style="color:#61768C;font-size:0.9em;"></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D26DCE90FA2EE0586AAF1F51D8C02570EF_w800h400.jpg" alt=""><p><strong>期间费用率升高3.5%</strong></p><p>公司2021年营业成本28.4亿，同比下降15.4%，低于营业收入19.4%的下降速度，毛利率下降2%。期间费用率为32.8%，较上年升高3.5%。</p><img id="image12" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2423A12BC51F21797E629ED63C8A7152C_w800h400.jpg" alt=""><p style="font-weight:bold;"></p><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202204222354361842>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)